GPT-4 Fails On Real Healthcare Tasks: New HealthBench Test Reveals The Gaps
By: mpost io|2025/05/14 14:45:05
0
Share
Large language models are everywhere — from search to coding and even patient-facing health tools. New systems are being introduced almost weekly, including tools that promise to automate clinical workflows. But can they actually be trusted to make real medical decisions? A new benchmark, called HealthBench, says not yet. According to the results, models like GPT-4 (from OpenAI) and Med-PaLM 2 (from Google DeepMind) still fall short on practical healthcare tasks, especially when accuracy and safety matter most.HealthBench is different from older tests. Instead of using narrow quizzes or academic question sets, it challenges AI models with real-world tasks. These include picking treatments, making diagnoses, and deciding what steps a doctor should take next. That makes the results more relevant to how AI might actually be used in hospitals and clinics.Across all tasks, GPT-4 performed better than previous models. But the margin was not enough to justify real-world deployment. In some cases, GPT-4 chose incorrect treatments. In others, it offered advice that could delay care or even increase harm. The benchmark makes one thing clear: AI might sound smart, but in medicine, that’s not good enough.Real Tasks, Real Failures: Where AI Still Breaks in MedicineOne of HealthBench’s biggest contributions is how it tests models. It includes 14 real-world healthcare tasks across five categories: treatment planning, diagnosis, care coordination, medication management, and patient communication. These aren’t made-up questions. They come from clinical guidelines, open datasets, and expert-authored resources that reflect how actual healthcare works.On many tasks, large language models showed consistent errors. For instance, GPT-4 often failed at clinical decision-making, such as determining when to prescribe antibiotics. In some examples, it was overprescribed. In others, it missed important symptoms. These types of mistakes are not just wrong — they could cause real harm if used in actual patient care.The models also struggled with complex clinical workflows. For example, when asked to recommend follow-up steps after lab results, GPT-4 gave generic or incomplete advice. It often skipped context, didn’t prioritize urgency, or lacked clinical depth. That makes it dangerous in cases where time and order of operations are critical.In medication-related tasks, accuracy dropped further. The models frequently mixed up drug interactions or gave outdated guidance. That’s especially alarming since medication errors are already one of the top causes of preventable harm in healthcare.Even when the models sounded confident, they weren’t always right. The benchmark revealed that fluency and tone didn’t match clinical correctness. This is one of the biggest risks of AI in health — it can “sound” human while being factually wrong.Why HealthBench Matters: Real Evaluation for Real ImpactUntil now, many AI health evaluations used academic question sets like MedQA or USMLE-style exams. These benchmarks helped measure knowledge but didn’t test whether models could think like doctors. HealthBench changes that by simulating what happens in actual care delivery.Instead of one-off questions, HealthBench looks at the entire decision chain — from reading a symptom list to recommending care steps. That gives a more complete picture of what AI can or can’t do. For instance, it tests if a model can manage diabetes across multiple visits or track lab trends over time.The benchmark also grades models on multiple criteria, not just accuracy. It checks for clinical relevance, safety, and the potential to cause harm. That means it’s not enough to get a question technically right — the answer also has to be safe and useful in real-life settings.Another strength of HealthBench is transparency. The team behind it released all prompts, scoring rubrics, and annotations. That allows other researchers to test new models, improve evaluations, and build on the work. It’s an open call to the AI community: if you want to claim your model is useful in healthcare, prove it here.GPT-4 and Med-PaLM 2 Still Not Ready for ClinicsDespite recent hype around GPT-4 and other large models, the benchmark shows they still make serious medical mistakes. In total, GPT-4 only achieved around 60–65% correctness on average across all tasks. In high-stakes areas like treatment and medication decisions, the score was even lower.Med-PaLM 2, a model tuned for healthcare tasks, didn’t perform much better. It showed slightly stronger accuracy in basic medical recall but failed at multi-step clinical reasoning. In several scenarios, it offered advice that no licensed physician would support. These include misidentifying red-flag symptoms and suggesting non-standard treatments.The report also highlights a hidden danger: overconfidence. Models like GPT-4 often deliver wrong answers in a confident, fluent tone. That makes it hard for users — even trained professionals — to detect errors. This mismatch between linguistic polish and medical precision is one of the key risks of deploying AI in healthcare without strict safeguards.To put it plainly: sounding smart isn’t the same as being safe.What Needs to Change Before AI Can Be Trusted in HealthcareThe HealthBench results aren’t just a warning. They also point to what AI needs to improve. First, models must be trained and evaluated using real-world clinical workflows, not just textbooks or exams. That means including doctors in the loop — not just as users, but as designers, testers, and reviewers.Second, AI systems should be built to ask for help when uncertain. Right now, models often guess instead of saying, “I don’t know.” That’s unacceptable in healthcare. A wrong answer can delay diagnosis, increase risk, or break patient trust. Future systems must learn to flag uncertainty and refer complex cases to humans.Third, evaluations like HealthBench must become the standard before real deployment. Just passing an academic test is no longer enough. Models must prove they can handle real decisions safely, or they should stay out of clinical settings entirely.The Path Ahead: Responsible Use, Not HypeHealthBench doesn’t say that AI has no future in healthcare. Instead, it shows where we are today — and how far there is still to go. Large language models can help with administrative tasks, summarization, or patient communication. But for now, they are not ready to replace or even reliably support doctors in clinical care.Responsible use means clear limits. It means transparency in evaluation, partnerships with medical professionals, and constant testing against real medical tasks. Without that, the risks are too high.The creators of HealthBench invite the AI and healthcare community to adopt it as a new standard. If done right, it could push the field forward — from hype to real, safe impact.The post GPT-4 Fails On Real Healthcare Tasks: New HealthBench Test Reveals The Gaps appeared first on Metaverse Post.
You may also like
The cryptocurrency industry has become a traditional industry
For entrepreneurs and retail investors still in this industry, they should either embrace the current changes or explore the next unpredictable field in cryptocurrency.
Chip frenzy cooling down? Morgan Stanley's Wilson: Funds are shifting towards AI supercomputing giants like Microsoft and Amazon
Morgan Stanley's chief equity strategist Wilson pointed out that the momentum in the semiconductor sector is waning, with the Philadelphia Semiconductor Index having dropped nearly 14% from its peak. Funds are shifting towards AI supercomputing giants like Microsoft, Amazon, and Meta, as well as sec...
Morning Report | Vitalik outlines Ethereum's long-term roadmap, Lean Ethereum will become the third major iteration; SK Hynix seeks to attract more AI investors by listing in the U.S
July 5 Market Important Events Overview
Trump, the best stock trader among U.S. presidents
Trump has almost turned the presidency into a business and maximized the conversion of presidential influence into commercial profits.
From ByteDance to Financial Freedom: How did "Byte Brother" Leto develop his investment judgment skills to achieve a turnaround of 30 million?
Speak with data and signals, validate judgments with A/B tests, and seek asymmetric returns with limited risk exposure.
Selling coins despite a loss of 55 million dollars, the faith in Strategy has reached the interest payment date
The moment faith was securitized, Bitcoin became a bill.
OUSD False Cooperation Controversy? The Credit Game of Stablecoins and Endorsements by Giants
The success of stablecoins does not rely on rallying a group of alliance members for marketing, but rather on whether they have real use cases and genuine users.
Q-Day Countdown: Will Quantum Computing End Cryptocurrency?
In the face of dormant coins being plundered by quantum computing power, should we firmly uphold the unalterable bottom line of "code is law," or should we enforce a soft fork to freeze legacy assets?
The ten years of Cloud on the Air: From corner coffee to global financial infrastructure
How did a remittance company grow into a financial infrastructure that can replace SWIFT; when it really reaches this scale, how should stablecoins be positioned for it; and what can AI integrate into this infrastructure?
$10,000 in TRUMP Token vs. $10,000 in Nasdaq: The "Trump Trade" That Actually Worked in 2026
TRUMP Token lost more than 96% after its launch, while Nasdaq stocks and NVIDIA delivered strong gains. Compare what happened to a $10,000 investment and explore why asset fundamentals matter more than market hype.
The impact of OUSD on Circle, Tether, and Paxos: not a single negative factor, but a more complex reshaping of competition
OUSD will not be the last new competitor; Circle needs to respond more actively in terms of products, distribution, and ecosystem collaboration.
Li Feifei's latest long article: When video generation, robots, and NVIDIA all claim to be world models, we need a taxonomy
Language gives machines a way to talk about the world. The world model is the means by which machines ultimately understand, imagine, reason, and interact with it.
Blaming the desolation of the cryptocurrency world on the rise of AI is a form of intellectual laziness
The emergence of giants signifies a mature business model. Although it will reduce speculative space, there is also enough room for error, allowing for the continuous emergence of new forces.
Strategy Founder: The Next 10 Years of Bitcoin
In the next decade, the biggest evolution of Bitcoin is precisely "responding to change with invariance." The four-year cycle is giving way to capital flows such as ETFs, corporate and sovereign reserves, and bank credit, while digital credit and digital currency will grow layer upon layer on top of...
Forbes Special Report: Stablecoin cross-border payments are faster now, but not cheaper yet
Cross-border payments using stablecoins are rapidly expanding, bringing speed and accessibility, but due to insufficient institutional liquidity, they have not yet delivered on their promised cost savings. The technology has been validated, and regulations are improving, but the industry has not yet...
A valuation of 8 billion dollars, doubling in 8 months! What makes the crypto-friendly bank Erebor Bank stand out?
Erebor is a high-profile experiment taking place at the intersection of banking, cryptocurrency, and industrial policy.
340 billion valuation: Li Yanhong's largest IPO, a seat in Kunlunxin's shares is hard to come by
As a core asset in Baidu's AI landscape, Kunlun Chip is expected to exceed Baidu's market value after going public, becoming an important bargaining chip in its turnaround battle.
Stablecoins are the "royalists" of the crypto world: Open USD brings the old currency system into play
The emergence of Open USD has shifted the competition for stablecoins from the market struggle of crypto startups to a battle for infrastructure involving traditional finance, payment networks, technology platforms, and public chain ecosystems.
The cryptocurrency industry has become a traditional industry
For entrepreneurs and retail investors still in this industry, they should either embrace the current changes or explore the next unpredictable field in cryptocurrency.
Chip frenzy cooling down? Morgan Stanley's Wilson: Funds are shifting towards AI supercomputing giants like Microsoft and Amazon
Morgan Stanley's chief equity strategist Wilson pointed out that the momentum in the semiconductor sector is waning, with the Philadelphia Semiconductor Index having dropped nearly 14% from its peak. Funds are shifting towards AI supercomputing giants like Microsoft, Amazon, and Meta, as well as sec...
Morning Report | Vitalik outlines Ethereum's long-term roadmap, Lean Ethereum will become the third major iteration; SK Hynix seeks to attract more AI investors by listing in the U.S
July 5 Market Important Events Overview
Trump, the best stock trader among U.S. presidents
Trump has almost turned the presidency into a business and maximized the conversion of presidential influence into commercial profits.
From ByteDance to Financial Freedom: How did "Byte Brother" Leto develop his investment judgment skills to achieve a turnaround of 30 million?
Speak with data and signals, validate judgments with A/B tests, and seek asymmetric returns with limited risk exposure.
Selling coins despite a loss of 55 million dollars, the faith in Strategy has reached the interest payment date
The moment faith was securitized, Bitcoin became a bill.
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Program:support@weex.com





